Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:39 PM
Ignite Modification Date:
2025-12-24 @ 10:39 PM
NCT ID:
NCT00886535
Eligibility Criteria:
Inclusion Criteria:
* Patients receiving tamoxifen for adjuvant therapy of breast cancer or ductal carcinoma in situ, or as chemoprevention
* Age 18 years and above
* May be pre- and post-menopausal
* Females
* Patients may be at any point in their hormonal treatment, but must have completed any planned surgery, radiation and chemotherapy
* Must use a reliable form of birth control
Exclusion Criteria:
* Pregnant
* Breastfeeding
* Concurrent use of corticosteroids, megestrol, or phenobarbital
* History of allergy to tamoxifen
* Unwilling to have a yearly gynecological exam
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00886535
Study Brief:
Protocol Section:
NCT00886535